The Trump administration’s efforts to raise scientific standards are justified, but its methods are shortsighted.

Raleigh-based Focal Medical, an oncology device company that received early funding from the North Carolina Biotechnology Center, has been acquired by a Florida biopharmaceutical company. Financial ...